We hypothesize that CBX7 exerts a tumor immune response by suppressing the immunological infiltration of M0 macrophages and attracting a significant number of resting mast cells, resulting in a better prognosis for patients with bladder cancer. The gene discussed is CBX7; the disease is urinary bladder carcinoma.